+8.2%
GSK vs VO
+15.0%
-6.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +1.3% | -2.5% | -1.8% |
| 7D | -1.1% | +0.2% | -1.3% | -1.3% |
| 30D | +7.8% | +2.0% | +5.8% | +6.8% |
| 3M | +0.3% | -0.3% | +0.6% | +0.4% |
| 6M | +3.4% | +7.3% | -3.8% | -0.9% |
| YTD | +5.9% | +15.0% | -9.1% | -3.1% |
| 1Y | +8.2% | +14.7% | -6.5% | -0.9% |
| All | +8.2% | +15.0% | -6.7% | -0.9% |
Cumulative growth
Daily Returns
Daily percentage return beside VO.
Daily Out/Under-Performance
Portfolio return minus VO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling